J. Wesley Boyd, MD, PhD
Opinion: The New Ketamine-Based Antidepressant Is a Rip-Off
Johnson & Johnson patented a form of the psychedelic with less research and a ridiculous price tag.
Forcing Psych Meds on Detained Children Perpetuates Distrust About Mental Health Care
The unethical treatment not only affects these kids, but it could have lasting impacts on people of color seeking mental health treatment.